New blood test could help millions of patients with gastrointestinal disorders

Study identifies test for high levels of vinculin antibodies in patients with irritable bowel syndrome

2013-10-16

(Press-News.org) LOS ANGELES (Oct. 15, 2013) – For the first time, a simple blood test may be the best way to determine if a patient is suffering from Irritable Bowel Syndrome (IBS), or another serious condition such as Inflammatory Bowel Disease (IBD,) according to Cedars-Sinai physician researcher Mark Pimentel, MD, lead author of a multicenter clinical trial.

Researchers conclusively identified a test for antibodies that form against a particular protein, vinculin, found in the guts of patients, many of whom suffered acute gastroenteritis at some point.

"This is a major breakthrough. It is the first test with a high specificity for IBS, likely based on a pathological mechanism of the disease," said Pimentel, the director of the Cedars-Sinai GI Motility Program and the GI Motility Laboratory. Pimentel is co-author of the study and results were presented for the first time this week at the American College of Gastroenterology's 78th Annual Scientific Meeting in San Diego, Calif.

In the study, 221 patients were evaluated; some had a diagnosis of IBS, some were diagnosed with IBD and some were healthy, with no symptoms. Anti-vinculin antibodies were significantly elevated in IBS patients as compared to those with IBD or those who were healthy.

"Until this study, there had been no accurate biomarkers identified specifically for IBS. The new blood test has the potential to distinguish IBS from IBD and reduce the need for unnecessary testing, expense and years of suffering," says Pimentel.

Irritable Bowel Syndrome is the most common gastrointestinal disorder in the U.S., afflicting 30 million people. Food poisoning has been identified as a significant risk factor for developing the disorder which is characterized by a cluster of symptoms including diarrhea, bloating and abdominal pain. But millions of patients are never diagnosed correctly. A simple blood test at the first sign of symptoms means patients who have IBS could get effective treatment sooner.

More than a decade ago, Pimentel went up against the conventional medical understanding of IBS when his research suggested the overgrowth of bacteria in the gut was a contributing cause of the condition. Today, antibiotics play a key therapeutic role in bringing relief to millions of patients. A definitive blood test for IBS would represent a significant new development.

### The study was performed in collaboration with physician scientists at Beth Israel Deaconess Medical GAS in Boston.

ELSE PRESS RELEASES FROM THIS DATE:

Researchers discover and treat toxic effects of ALS mutation in neurons made from patients' skin cells

2013-10-16

Researchers have discovered how the most common genetic abnormality in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) kills neurons and have successfully developed a therapeutic strategy to block this neurodegeneration in neurons made from the skin cells of ALS patients. The findings, which are published online in the October 16th issue of the Cell Press journal Neuron, have important implications for treating patients with these debilitating, currently incurable neurodegenerative diseases. The most common genetic mutation in ALS and FTD is an abnormal ...

Rare gene mutation sheds light on protein's role in brain development

2013-10-16

DURHAM, N.C. – Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments. An international team of scientists, led by genetic researchers at Duke Medicine, has solved the case by identifying a recessive gene mutation that reduces the abundance of a certain protein that previously had not been known to affect brain development. The gene mutation causes a defect in the body's synthesis of a nutrient ...

'Individualized' therapy for the brain targets specific gene mutations causing dementia and ALS

2013-10-16

Johns Hopkins scientists have developed new drugs that — at least in a laboratory dish — appear to halt the brain-destroying impact of a genetic mutation at work in some forms of two incurable diseases, amyotrophic lateral sclerosis (ALS) and dementia. They made the finding by using neurons they created from stem cells known as induced pluripotent stem cells (iPS cells), which are derived from the skin of people with ALS who have a gene mutation that interferes with the process of making proteins needed for normal neuron function. "Efforts to treat neurodegenerative ...

Study shows how Staph toxin disarms the immune system

2013-10-16

Researchers at NYU Langone Medical Center have discovered a new mechanism by which the deadly Staphylococcus aureus bacteria attack and kill off immune cells. Their findings, published today in the journal Cell Host & Microbe, explain a critical survival tactic of a pathogen that causes more skin and heart infections than any other microbe, and kills more than 100,000 Americans every year. "What we've found is that Staph unleashes a multi-purpose toxin capable of killing different types of immune cells by selectively binding to surface receptors," says Victor J. Torres, ...

ALMA probes mysteries of jets from giant black holes

2013-10-16

There are supermassive black holes -- with masses up to several billion solar masses -- at the hearts of almost all galaxies in the Universe, including our own galaxy, the Milky Way. In the remote past, these bizarre objects were very active, swallowing enormous quantities of matter from their surroundings, shining with dazzling brilliance, and expelling tiny fractions of this matter through extremely powerful jets. In the current Universe, most supermassive black holes are much less active than they were in their youth, but the interplay between jets and their surroundings ...

Over 1 million community health center patients will remain uninsured and left out of health reform

2013-10-16

WASHINGTON, DC and NEW YORK (Oct. 16, 2013)— A new report by the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at the George Washington University School of Public Health and Health Services (SPHHS) examines the impact of health reform on community health centers (CHCs) and their patients. "Assessing the Potential Impact of the Affordable Care Act on Uninsured Community Health Center Patients: A Nationwide and State-by-State Analysis," estimates that more than 5 million health center patients would have gained coverage had all states participated ...

Mice modeling schizophrenia show key brain network in overdrive

2013-10-16

Working with mice genetically engineered to display symptoms of schizophrenia, neuroscientists at the RIKEN-MIT Center for Neural Circuit Genetics at the Picower Institute for Learning and Memory at MIT have uncovered a faulty brain mechanism that may underlie schizophrenia and other psychiatric disorders in humans. The study, to appear in the Oct. 16 issue of Neuron, is the first to tie a specific brain network abnormality to schizophrenia, whose symptoms range from disorganized thinking, hallucinations and paranoia to an inability to plan for the future. "Our study ...

Schizophrenia linked to abnormal brain waves

2013-10-16

CAMBRIDGE, MA -- Schizophrenia patients usually suffer from a breakdown of organized thought, often accompanied by delusions or hallucinations. For the first time, MIT neuroscientists have observed the neural activity that appears to produce this disordered thinking. The researchers found that mice lacking the brain protein calcineurin have hyperactive brain-wave oscillations in the hippocampus while resting, and are unable to mentally replay a route they have just run, as normal mice do. Mutations in the gene for calcineurin have previously been found in some schizophrenia ...

Scientists develop heat-resistant materials that could vastly improve solar cell efficiency

2013-10-16

Scientists have created a heat-resistant thermal emitter that could significantly improve the efficiency of solar cells. The novel component is designed to convert heat from the sun into infrared light, which can than be absorbed by solar cells to make electricity – a technology known as thermophotovoltaics. Unlike earlier prototypes that fell apart at temperatures below 2200 degrees Fahrenheit (1200 degrees Celsius), the new thermal emitter remains stable at temperatures as high as 2500 F (1400 C). "This is a record performance in terms of thermal stability and a major ...

A bad break for fake pearls

2013-10-16

For a long time, it was thought impossible to isolate a pearl's genetic material. Now, a Swiss research team has achieved this elusive goal. Scientists Joana Meyer, from the ETH Institute of Integrative Biology group headed by Prof. Bruce McDonald, and Laurent Cartier of the Swiss Gemmological Institute (SSEF), under the direction of Michael Krzemnicki, succeeded for the first time in extracting trace amounts of DNA from a variety of cultured pearls in an almost non-destructive way. Using the genetic code, they were able to differentiate pearls from three different species ...

LAST 30 PRESS RELEASES:

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Negativity about vaccines surged on Twitter after COVID-19 jabs become available

Global measles cases almost double in a year

Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds